BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 28992434)

  • 1. Targeting Epigenetics in Cancer.
    Bennett RL; Licht JD
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
    Bayo J; Dalvi MP; Martinez ED
    Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
    Biswas S; Rao CM
    Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the epigenetic regulation of antitumour immunity.
    Hogg SJ; Beavis PA; Dawson MA; Johnstone RW
    Nat Rev Drug Discov; 2020 Nov; 19(11):776-800. PubMed ID: 32929243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and classes of epigenetic drugs for cancer.
    Dhanak D; Jackson P
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
    Simó-Riudalbas L; Esteller M
    Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting components of epigenome by small molecules.
    You JS; Han JH
    Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecular modulators of cancer-associated epigenetic mechanisms.
    Itoh Y; Suzuki T; Miyata N
    Mol Biosyst; 2013 May; 9(5):873-96. PubMed ID: 23511667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
    Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status of Epigenetics and Anticancer Drug Discovery.
    Jin P; Chen X
    Anticancer Agents Med Chem; 2016; 16(6):699-712. PubMed ID: 26567620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone methyltransferase inhibitors: novel epigenetic agents for cancer treatment.
    Zagni C; Chiacchio U; Rescifina A
    Curr Med Chem; 2013; 20(2):167-85. PubMed ID: 23210854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromodomain inhibitors and cancer therapy: From structures to applications.
    Pérez-Salvia M; Esteller M
    Epigenetics; 2017 May; 12(5):323-339. PubMed ID: 27911230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy.
    Myasoedova VA; Sukhorukov V; Grechko AV; Zhang D; Romanenko E; Orekhov V; Orekhov AN
    Curr Pharm Des; 2019; 25(6):635-641. PubMed ID: 30950345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Therapies and Potential Drugs for Treating Human Cancer.
    Lin SQ; Li X
    Curr Drug Targets; 2020; 21(11):1068-1083. PubMed ID: 32209040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors.
    Zhang Y; Rong D; Li B; Wang Y
    J Med Chem; 2021 Jun; 64(12):7900-7925. PubMed ID: 33599482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics.
    Li Y; Li Z; Zhu WG
    Curr Med Chem; 2019; 26(8):1328-1350. PubMed ID: 28933282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Molecules Targeting the Specific Domains of Histone-Mark Readers in Cancer Therapy.
    Zhu H; Wei T; Cai Y; Jin J
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.